Similarities between Befiradol and Neurolixis
Befiradol and Neurolixis have 6 things in common (in Unionpedia): F-15,599, Laboratoires Pierre Fabre, Parkinson's disease, Parkinson's UK, The Michael J. Fox Foundation, 5-HT1A receptor.
F-15,599
F-15,599, also known as NLX-101, is a very potent and highly selective 5-HT1A receptor full agonist.
Befiradol and F-15,599 · F-15,599 and Neurolixis ·
Laboratoires Pierre Fabre
Laboratoires Pierre Fabre is a French multinational pharmaceutical and cosmetics company.
Befiradol and Laboratoires Pierre Fabre · Laboratoires Pierre Fabre and Neurolixis ·
Parkinson's disease
Parkinson's disease (PD) is a long-term degenerative disorder of the central nervous system that mainly affects the motor system.
Befiradol and Parkinson's disease · Neurolixis and Parkinson's disease ·
Parkinson's UK
Parkinson's UK is a Parkinson's research and support charity in the United Kingdom.
Befiradol and Parkinson's UK · Neurolixis and Parkinson's UK ·
The Michael J. Fox Foundation
The Michael J. Fox Foundation for Parkinson's Research is dedicated to finding a cure for Parkinson's disease (PD) through funded research and ensuring the development of improved therapies for those living with Parkinson's today.
Befiradol and The Michael J. Fox Foundation · Neurolixis and The Michael J. Fox Foundation ·
5-HT1A receptor
The serotonin 1A receptor (or 5-HT1A receptor) is a subtype of serotonin receptor (5-HT receptor) that binds the neurotransmitter serotonin (5-hydroxytryptamine, 5-HT).
5-HT1A receptor and Befiradol · 5-HT1A receptor and Neurolixis ·
The list above answers the following questions
- What Befiradol and Neurolixis have in common
- What are the similarities between Befiradol and Neurolixis
Befiradol and Neurolixis Comparison
Befiradol has 24 relations, while Neurolixis has 12. As they have in common 6, the Jaccard index is 16.67% = 6 / (24 + 12).
References
This article shows the relationship between Befiradol and Neurolixis. To access each article from which the information was extracted, please visit: